INHIBITOREN VON (ALPHA-V)(BETA-6)-INTEGRIN

European patent · EP4159727 · In force

Register entry

Publication number
EP4159727
Application number
EP22205911
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Feb 27, 2018
Published
Apr 5, 2023
Granted
Apr 8, 2026
Protection ends at the latest
Feb 26, 2038
Next annual fee due
Feb 28, 2027
IPC classes
C07D 401/12 (2006.01)
C07D 471/04 (2006.01)
C07D 519/00 (2006.01)
A61P 11/00 (2006.01)
A61P 13/12 (2006.01)
A61P 19/02 (2006.01)
A61P 25/08 (2006.01)
A61P 35/00 (2006.01)
A61P 35/02 (2006.01)
A61P 37/02 (2006.01)
A61P 1/16 (2006.01)
Priority
US 201762464693 P 28.02.2017
Divided from
EP18761396
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 8, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 08.04.2026

Parties

Inventor

BREWER, Mark

Reading, R98 0NR, GB

BURSAVICH, Matthew, Gregory

Needham, 02494, US

GERASYUTO, Aleksey, Lgorevich

Flemington, 08822, US

HAHN, Kristopher, Neil

Medford, 02155, US

HARRISON, Bryce, Alden

Framingham, 01701, US

KONZE, Kyle, David

Brooklyn, 11215, US

LIN, Fu-yang

Sudbury, 01776, US

LIPPA, Blaise, Scott

Newton, 02459, US

LUGOVSKOY, Alexey, Alexandrovich

Belmont, 02478, US

ROGERS, Bruce, Nelsen

Belmont, 02478, US

SVENSSON, Mats, Ake

New York, 10011, US

TROAST, Dawn, Marie

Bedford, 01730, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.